ARMATA PHARMACEUTICALS INC (ARMP)
US04216R1023 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -79.58M | -69.05M | -36.92M | -23.16M | -22.18M | |||
| Depreciation Amortization | 1.06M | 972.00K | 890.00K | 1.17M | 1.11M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -4.01M | -9.65M | 440.00K | -3.22M | -870.00K | |||
| Other non cash items | 42.09M | 30.30M | 3.11M | 1.63M | 3.67M | |||
| OPERATING CASH FLOW | -40.44M | -47.42M | -32.48M | -23.58M | -18.27M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -6.38M | -8.14M | -2.21M | -1.30M | -820.00K | |||
| Other Investing Activity | N/A | 10.00K | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -6.37M | -8.13M | -2.21M | -1.30M | -820.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 59.33M | 54.03M | N/A | 0.00 | 720.00K | |||
| Stock Issued/Repurchased | 47.00K | 5.00K | 44.52M | 26.93M | 23.06M | |||
| Dividend Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other Financing Activity | N/A | -43.00K | -500.00K | -1.41M | -570.00K | |||
| FINANCING CASH FLOW | 59.33M | 53.99M | 44.02M | 25.52M | 23.21M | |||
| CHANGE IN CASH | 12.52M | -1.57M | 9.33M | 640.00K | 4.12M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -40.44M | -47.42M | -32.48M | -23.58M | -18.27M | |||
| Capital Expenditure | -6.38M | -8.14M | -2.21M | -1.30M | -820.00K | |||
| FREE CASH FLOW | -46.82M | -55.57M | -34.69M | -24.88M | -19.09M | |||
All data in USD